Carfilzomib or bortezomib in relapsed or refractory multiple myeloma (ENDEAVOR): an interim overall survival analysis of an open-label, randomised, phase 3 trial | Lancet Oncology, The | 2017 | 248 |
Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis | Lancet Neurology, The | 2017 | 243 |
Molecular Classification of Hepatocellular Adenoma Associates With Risk Factors, Bleeding, and Malignant Transformation | Gastroenterology | 2017 | 198 |
Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study | Journal of Medical Genetics | 2017 | 193 |
Idelalisib or placebo in combination with bendamustine and rituximab in patients with relapsed or refractory chronic lymphocytic leukaemia: interim results from a phase 3, randomised, double-blind, placebo-controlled trial | Lancet Oncology, The | 2017 | 173 |
A leadless pacemaker in the real-world setting: The Micra Transcatheter Pacing System Post-Approval Registry | Heart Rhythm | 2017 | 168 |
Liver transplantation in the most severely ill cirrhotic patients: A multicenter study in acute-on-chronic liver failure grade 3 | Journal of Hepatology | 2017 | 165 |
Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM): EURObservational Research Programme in conjunction with the Heart Failure Association of the European Society of Cardiology Study Group on PPCM | European Journal of Heart Failure | 2017 | 114 |
The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice | Journal of Neurology, Neurosurgery and Psychiatry | 2017 | 109 |
Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): A study of 157 patients by the Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires and the European Respiratory Society Taskforce on eosinophilic granulomatosis with polyangiitis (Churg-Strauss) | Autoimmunity Reviews | 2017 | 98 |
Omalizumab in children with uncontrolled allergic asthma: Review of clinical trial and real-world experience | Journal of Allergy and Clinical Immunology | 2017 | 93 |
Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease | European Heart Journal | 2017 | 88 |
CD163-positive tumor-associated macrophages and CD8-positive cytotoxic lymphocytes are powerful diagnostic markers for the therapeutic stratification of osteosarcoma patients: An immunohistochemical analysis of the biopsies fromthe French OS2006 phase 3 trial | OncoImmunology | 2017 | 80 |
Efficacy and safety of long-acting pasireotide or everolimus alone or in combination in patients with advanced carcinoids of the lung and thymus (LUNA): an open-label, multicentre, randomised, phase 2 trial | Lancet Oncology, The | 2017 | 70 |
Effect of Azithromycin on Airflow Decline-Free Survival After Allogeneic Hematopoietic Stem Cell Transplant: The ALLOZITHRO Randomized Clinical Trial | JAMA - Journal of the American Medical Association | 2017 | 63 |
Pendred syndrome | Best Practice and Research in Clinical Endocrinology and Metabolism | 2017 | 59 |
Hemidesmosome integrity protects the colon against colitis and colorectal cancer | Gut | 2017 | 54 |
Outcome and Treatment of Nocardiosis After Solid Organ Transplantation: New Insights From a European Study | Clinical Infectious Diseases | 2017 | 54 |
French Registry on Acute ST-elevation and non-ST-elevation Myocardial Infarction 2015 (FAST-MI 2015). Design and baseline data | Archives of Cardiovascular Diseases | 2017 | 52 |
Cabergoline for Cushing's disease: a large retrospective multicenter study | European Journal of Endocrinology | 2017 | 51 |
The LIN28B/let-7 axis is a novel therapeutic pathway in multiple myeloma | Leukemia | 2017 | 50 |
Impact of prior treatment on patients with relapsed multiple myeloma treated with carfilzomib and dexamethasone vs bortezomib and dexamethasone in the phase 3 ENDEAVOR study | Leukemia | 2017 | 49 |
Role of Hydrophobins in Aspergillus fumigatus | Journal of Fungi (Basel, Switzerland) | 2017 | 46 |
Performance of 18F-FDG PET/CT in the Characterization of Adrenal Masses in Noncancer Patients: A Prospective Study | Journal of Clinical Endocrinology and Metabolism | 2017 | 44 |
Total Endovascular Treatment of Aortic Arch Disease Using an Arch Endograft With 3 Inner Branches | Journal of Endovascular Therapy | 2017 | 44 |